POINT Biopharma Global Inc. Quarterly Common Stock, Value, Issued in USD from Q4 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
POINT Biopharma Global Inc. quarterly Common Stock, Value, Issued history and growth rate from Q4 2020 to Q3 2023.
  • POINT Biopharma Global Inc. Common Stock, Value, Issued for the quarter ending September 30, 2023 was $10.6K, a 1.64% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $10.6K +$171 +1.64% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $10.6K +$1.56K +17.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $10.6K +$1.56K +17.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $10.6K +$1.55K +17.2% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 $10.4K +$1.39K +15.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $9.01K $0 0% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $9.01K Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $9.01K +$3.55K +64.9% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $9.01K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $9.01K Jun 30, 2021 10-Q 2021-08-13
Q4 2020 $5.47K Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.